Table 3.

Percentage inhibition (%) of MLR-Bf significant IgG and its isotypes

Different group of subjects	Proportionate change in percentage inhibition of MLR-Bf significant IgG and its isotypes in terms of interquartile range (IQR)
	IgG		IgG1		IgG2		IgG3		IgG4
	W × H (1:2)	H × W (2:1)	W × H (1:2)	H × W (2:1)	W × H (1:2)	H × W (2:1)	W × H (1:2)	H × W (2:1)	W × H (1:2)	H × W (2:1)
Ist trimester	39 (35–67)	26 (21–63)	22 (18–28)	24 (15–26)	17 (-11–37)	21 (7–42)	68 (61–68) *	64 (60–63) *	19 (17–45)	17 (11–21)
IInd trimester	42 (28–71)	39 (35–64)	18 (15–24)	17 (14–19)	12 (3–33)	11 (9–15)	61 (63–70) *	62(61–67) *	29 (-14–33)	4 (-17–8)
IIIrd trimester	27 (21–62)	35 (27–67)	-14 (-27–9)	13 (-8–27)	15 (9–23)	17 (14–21)	67 (61–82) *	71(62–76) *	15 (15–28)	13 (9–16)
Post delivery period	44 (20–68)	25 (23–68)	17 (-3–20)	15 (10–30)	5 (-9–19)	11 (7–31)	47 (14–47)	41(23–52)	8 (4–17)	11 (6–22)
Pre immunized RSA Women	34 (28–47)	28 (23–61)	6 (-12–9)	-6 (-11–2)	2 (24–11)	5 (-22–7)	43 (17–37)	38(21–36)	6 (-12–6)	8 (5–19)
Post immunized RSA Women	51 (44–69)	60 (57–73)	-7 (-16–7)	4 (-12–6)	12 (6–31)	21 (11–29)	67 (64–82) *	67(62–71) *	21 (19–26)	15 (10–30)
Healthy male	-9 (-21–2)	-17 (-8–4)	-17 (-19–2)	-8 (-11–3)	-15 (-27–5)	4 (-17–2)	-11 (-19–9)	-12(-18–7)	-6 (-29–4)	-11 (-18–19)
Unmarried females	-17 (-24–6)	-23 (-35–2)	-7 (-11–3)	3 (-7–10)	-5 (-17–4)	9 (-21–12)	15 (-11–3)	12(-6–17)	14 (11–22)	25 (24–27)

1:2 (non irradiated cells of control female × irradiated cells of control male), 2:1 (non irradiated cells of control male × irradiated cells of control female) W = wife, H = husband. Values given in the table are calculated as percentage inhibition (%) against the base line measurement and shown as median and interquartile range(IQR), n = 10.*P < 0.001